Inventor
SIDRANSKY DAVID
US39 patents
⚠️ This page may combine multiple inventors who share the name “SIDRANSKY DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS MED
15 patentsUS7524633B2Apr 28, 2009
Method of detection of prostate cancer
UNIV JOHNS HOPKINS MED89 citations98
US6235470B1May 22, 2001
Detection of neoplasia by analysis of saliva
UNIV JOHNS HOPKINS MED70 citations96
US5856094AJan 5, 1999
Method of detection of neoplastic cells
UNIV JOHNS HOPKINS MED64 citations96
US7794929B2Sep 14, 2010
Genomic screen for epigenetically silenced genes associated with cancer
UNIV JOHNS HOPKINS MED48 citations92
US6291163B1Sep 18, 2001
Method for detecting cell proliferative disorders
UNIV JOHNS HOPKINS MED24 citations92
US6025127AFeb 15, 2000
Nucleic acid mutation detection in histologic tissue
UNIV JOHNS HOPKINS MED27 citations92
US5726019AMar 10, 1998
Analysis of sputum by amplification and detection of mutant nucleic acid sequences
UNIV JOHNS HOPKINS MED24 citations92
US7601521B2Oct 13, 2009
Detection of nucleic acid mutation associated with cancer by analysis of saliva
UNIV JOHNS HOPKINS MED8 citations84
US6780592B2Aug 24, 2004
Method for detecting cell proliferative disorders
UNIV JOHNS HOPKINS MED11 citations74
US5908920AJun 1, 1999
Cell cycle regulatory gene
UNIV JOHNS HOPKINS MED6 citations74
US5767258AJun 16, 1998
Cell cycle regulatory gene
UNIV JOHNS HOPKINS MED6 citations74
US5561041AOct 1, 1996
Nucleic acid mutation detection by analysis of sputum
UNIV JOHNS HOPKINS MED14 citations74
US7781161B2Aug 24, 2010
Genomic screen for epigenetically silenced tumor suppressor genes
UNIV JOHNS HOPKINS MED6 citations60
US7279312B2Oct 9, 2007
Nucleic acid mutation detection by analysis of saliva
UNIV JOHNS HOPKINS MED0 citations52
US6204374B1Mar 20, 2001
Cell cycle regulatory gene
UNIV JOHNS HOPKINS MED0 citations52
UNIV JOHNS HOPKINS
15 patentsUS7378233B2May 27, 2008
BRAF mutation T1796A in thyroid cancers
UNIV JOHNS HOPKINS125 citations96
US6605433B1Aug 12, 2003
Mitochondrial dosimeter
UNIV JOHNS HOPKINS108 citations96
US7252935B2Aug 7, 2007
Method of detection of prostate cancer
UNIV JOHNS HOPKINS27 citations92
US5935787AAug 10, 1999
Detection of hypermutable nucleic acid sequence in tissue
UNIV JOHNS HOPKINS29 citations92
US6476206B1Nov 5, 2002
p40 protein acts as an oncogene
UNIV JOHNS HOPKINS17 citations89
US7468425B2Dec 23, 2008
p40 protein acts as an oncogene
UNIV JOHNS HOPKINS9 citations81
US7319023B2Jan 15, 2008
Detection of hypermutable nucleic acid sequence in tissue
UNIV JOHNS HOPKINS2 citations63
US6479234B1Nov 12, 2002
Detection of hypermutable nucleic acid sequence in tissue and body fluids
UNIV JOHNS HOPKINS2 citations63
US10428391B2Oct 1, 2019
Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods
UNIV JOHNS HOPKINS1 citations59
US10888549B2Jan 12, 2021
Pharmaceutical agents targeting cancer stem cells
UNIV JOHNS HOPKINS0 citations52
US7923460B2Apr 12, 2011
BRAF mutation T1796A in thyroid cancers
UNIV JOHNS HOPKINS1 citations50
US7709202B2May 4, 2010
Molecular characteristics of non-small cell lung cancer
UNIV JOHNS HOPKINS0 citations47
US10457992B2Oct 29, 2019
Hypermethylation biomarkers associated with poor survival outcomes for head and neck squamous cell cancer
UNIV JOHNS HOPKINS0 citations32
US10801071B2Oct 13, 2020
TGF(β)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicator of resistance to EGFR inhibitors
UNIV JOHNS HOPKINS0 citations31
US9809864B2Nov 7, 2017
Dual sequence-capture method for quantifying trans renal HPV DNA in urine
UNIV JOHNS HOPKINS0 citations27